EFM

E Fund Management Portfolio holdings

AUM $2.1B
1-Year Est. Return 23.31%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+23.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.09B
AUM Growth
+$101M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
437
New
Increased
Reduced
Closed

Top Buys

1
+$23.6M
2
+$18.5M
3
+$17.6M
4
AMZN icon
Amazon
AMZN
+$15.6M
5
META icon
Meta Platforms (Facebook)
META
+$14.9M

Top Sells

1
+$92.1M
2
+$15.6M
3
+$9.67M
4
YMM icon
Full Truck Alliance
YMM
+$9.6M
5
TME icon
Tencent Music
TME
+$8.7M

Sector Composition

1 Technology 37.79%
2 Consumer Discretionary 26.64%
3 Communication Services 10.64%
4 Healthcare 6.89%
5 Financials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
376
MannKind Corp
MNKD
$853M
$124K 0.01%
24,667
+2,628
NRIX icon
377
Nurix Therapeutics
NRIX
$1.58B
$122K 0.01%
+10,288
MYGN icon
378
Myriad Genetics
MYGN
$429M
$122K 0.01%
13,720
+1,968
NTLA icon
379
Intellia Therapeutics
NTLA
$1.58B
$120K 0.01%
16,831
-1,222
VIR icon
380
Vir Biotechnology
VIR
$1.55B
$104K 0.01%
+15,993
F icon
381
Ford
F
$46.7B
$102K ﹤0.01%
10,208
AVXL icon
382
Anavex Life Sciences
AVXL
$436M
$102K ﹤0.01%
+11,911
RCKT icon
383
Rocket Pharmaceuticals
RCKT
$529M
$97.2K ﹤0.01%
14,567
+3,513
COGT icon
384
Cogent Biosciences
COGT
$5.79B
$93.9K ﹤0.01%
15,670
+4,290
ETNB
385
DELISTED
89bio
ETNB
$93.3K ﹤0.01%
+12,827
IBRX icon
386
ImmunityBio
IBRX
$8.44B
$91.3K ﹤0.01%
30,331
-8,569
DAWN icon
387
Day One Biopharmaceuticals
DAWN
$2.21B
$88.3K ﹤0.01%
11,136
-140
RCUS icon
388
Arcus Biosciences
RCUS
$2.81B
$82.4K ﹤0.01%
+10,498
KURA icon
389
Kura Oncology
KURA
$771M
$80.9K ﹤0.01%
12,252
+1,951
CCG icon
390
Cheche Group
CCG
$64.4M
$70.5K ﹤0.01%
+83,069
ALT icon
391
Altimmune
ALT
$453M
$67.1K ﹤0.01%
13,427
+2,268
EBS icon
392
Emergent Biosolutions
EBS
$431M
$50.5K ﹤0.01%
10,383
+145
RLAY icon
393
Relay Therapeutics
RLAY
$1.81B
$50.2K ﹤0.01%
19,165
+1,511
VERV
394
DELISTED
Verve Therapeutics
VERV
$48.1K ﹤0.01%
+10,522
AKBA icon
395
Akebia Therapeutics
AKBA
$404M
$37.1K ﹤0.01%
19,311
+6,595
SANA icon
396
Sana Biotechnology
SANA
$873M
$30.6K ﹤0.01%
18,236
-3,966
HUMA icon
397
Humacyte
HUMA
$216M
$29.2K ﹤0.01%
17,133
+788
SCLX icon
398
Scilex Holding
SCLX
$59.3M
$7.81K ﹤0.01%
898
ABUS icon
399
Arbutus Biopharma
ABUS
$839M
– –
-10,385
ANNX icon
400
Annexon
ANNX
$853M
– –
-15,447
14 15
16
17 18